BOSTON SCIENTIFIC CORP — Director's Dealing 2025

Jun 30, 2025

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: BOSTON SCIENTIFIC CORP (BSX)
CIK: 0000885725
Period of Report: 2025-06-30

Reporting Person: Monson Jonathan (EVP and CFO)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	34727.0000	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Restricted Stock Units	$	2028-02-12	Common Stock (3462.0000)		Direct
Restricted Stock Units	$	2029-02-13	Common Stock (7066.0000)		Direct
Restricted Stock Units	$	2027-02-14	Common Stock (2116.0000)		Direct
Restricted Stock Units	$	2026-02-16	Common Stock (990.0000)		Direct
Restricted Stock Units	$	2025-08-02	Common Stock (1090.0000)		Direct
Restricted Stock Units	$	2026-12-01	Common Stock (3562.0000)		Direct
Stock Option (Right to Buy)	$27.0900	2028-02-15	Common Stock (12004.0000)		Direct
Stock Option (Right to Buy)	$37.5000	2031-02-17	Common Stock (14299.0000)		Direct
Stock Option (Right to Buy)	$40.1200	2029-02-21	Common Stock (8605.0000)		Direct
Stock Option (Right to Buy)	$42.1600	2030-02-18	Common Stock (10346.0000)		Direct
Stock Option (Right to Buy)	$42.9000	2029-07-01	Common Stock (10692.0000)		Direct
Stock Option (Right to Buy)	$44.1900	2032-02-16	Common Stock (13180.0000)		Direct
Stock Option (Right to Buy)	$45.8800	2031-08-02	Common Stock (15503.0000)		Direct
Stock Option (Right to Buy)	$47.2800	2033-02-14	Common Stock (12702.0000)		Direct
Stock Option (Right to Buy)	$56.1400	2033-12-01	Common Stock (10543.0000)		Direct
Stock Option (Right to Buy)	$64.9900	2034-02-12	Common Stock (14180.0000)		Direct
Stock Option (Right to Buy)	$106.1400	2035-02-13	Common Stock (7165.0000)		Direct

Footnotes

F1: Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 12, 2025, the first anniversary of the date of grant.

F2: This amount represents the unvested portion of RSUs awarded on February 12, 2024, which will continue to vest in three remaining installments on the anniversary of the date of grant.

F3: Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.

F4: Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 13, 2026, the first anniversary of the date of grant.

F5: Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 14, 2024, the first anniversary of the date of grant.

F6: This amount represents the unvested portion of RSUs awarded on February 14, 2023, which will continue to vest in two remaining installments on the anniversary of the date of grant.

F7: Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 16, 2023, the first anniversary of the date of grant.

F8: This amount represents the unvested portion of RSUs awarded on February 16, 2022, which will continue to vest in one remaining installment on the anniversary of the date of grant.

F9: Shares of common stock will be issued to the reporting person in four equal annual installments beginning on August 2, 2022, the first anniversary of the date of grant.

F10: This amount represents the unvested portion of RSUs awarded on August 2, 2021, which will continue to vest in one remaining installment on the anniversary of the date of grant.

F11: Shares of common stock will be issued to the reporting person in full on December 1, 2026, the third anniversary of the date of grant.

F12: Grant to the reporting person of an option to purchase 12,004 shares of common stock vesting in four equal annual installments beginning on February 15, 2019, the first anniversary of the date of grant.

F13: Grant to the reporting person of an option to purchase 14,299 shares of common stock vesting in four equal annual installments beginning on February 17, 2022, the first anniversary of the date of grant.

F14: Grant to the reporting person of an option to purchase 8,605 shares of common stock vesting in four equal annual installments beginning on February 21, 2020, the first anniversary of the date of grant.

F15: Grant to the reporting person of an option to purchase 10,346 shares of common stock vesting in four equal annual installments beginning on February 18, 2021, the first anniversary of the date of grant.

F16: Grant to the reporting person of an option to purchase 10,692 shares of common stock vesting in four equal annual installments beginning on July 1, 2020, the first anniversary of the date of grant.

F17: Grant to the reporting person of an option to purchase 13,180 shares of common stock vesting in four equal annual installments beginning on February 16, 2023, the first anniversary of the date of grant.

F18: Grant to the reporting person of an option to purchase 15,503 shares of common stock vesting in four equal annual installments beginning on August 2, 2022, the first anniversary of the date of grant.

F19: Grant to the reporting person of an option to purchase 12,702 shares of common stock vesting in four equal annual installments beginning on February 14, 2024, the first anniversary of the date of grant.

F20: Grant to the reporting person of an option to purchase 10,543 shares of common stock vesting in full on December 1, 2026, the third anniversary of the date of grant.

F21: Grant to the reporting person of an option to purchase 14,180 shares of common stock vesting in four equal annual installments beginning on February 12, 2025, the first anniversary of the date of grant.

F22: Grant to the reporting person of an option to purchase 7,165 shares of common stock vesting in four equal annual installments beginning on February 13, 2026, the first anniversary of the date of grant.